Indivior Pharmaceuticals INDV
NASDAQ INDV
$37.80 -1.24 (-3.18%)
As of: Aug 20, 2026 · 3:59 PM EDT

Indivior Pharmaceuticals (INDV) Return on Invested Capital Growth (1y) (2025 - 2026)

Indivior Pharmaceuticals (INDV) Return on Invested Capital Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (1y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 0.00
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 0.00
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 1.00
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 3.00
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Indivior Pharmaceuticals 4.51 Bn 4.29 Bn 294.00 Mn 4.00

Historic Data

Download Data
DateValue
Jun 30, 2026 4.00
Mar 31, 2026 5.00
Dec 31, 2025 3.00